Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis
Clinical trial NCT06688253 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06688253
- Sponsor
- Rambam Health Care Campus
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2025-01-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.